Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings
The Food and Drug Administration (FDA) has issued a Public Health Advisory to warn of the risk of skin burns in patients wearing transdermal patches (medicated patches applied to the skin) who are undergoing magnetic resonance imaging (MRI) scans. Transdermal patches are applied to the skin and commonly deliver pain medications, heart medications, hormones, or nicotine. Certain transdermal patches contain aluminum or other metals in the backing of the patches, which can overheat during an MRI scan and cause skin burns in the immediate area of the patch. The FDA is in the process of reviewing the labeling and the metal content of all patches to ensure that those made with materials containing metal provide a warning about the risk of burns to patients who wear the patches during an MRI scan. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm111313.htm
Learn More

Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings
The Food and Drug Administration (FDA) has issued a Public Health Advisory to warn of the risk of skin burns in patients wearing transdermal patches (medicated patches applied to the skin) who are undergoing magnetic resonance imaging (MRI) scans. Transdermal patches are applied to the skin and commonly deliver pain medications, heart medications, hormones, or nicotine. Certain transdermal patches contain aluminum or other metals in the backing of the patches, which can overheat during an MRI scan and cause skin burns in the immediate area of the patch. The FDA is in the process of reviewing the labeling and the metal content of all patches to ensure that those made with materials containing metal provide a warning about the risk of burns to patients who wear the patches during an MRI scan. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PublicHealthAdvisories/ucm111313.htm
Learn More

Date Published Title Drug Source
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Nitroglycerin FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Nicotine FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Scopolamine FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Estradiol and Norethindrone FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Methylphenidate FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Fentanyl FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Estradiol FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Ortho Evra FDA
2009-03-09 Risk of Burns during MRI Scans from Transdermal Drug Patches with Metallic Backings Oxybutynin FDA
2009-02-26 Boxed Warning Added to Metoclopramide Labeling Metoclopramide HCl FDA
2009-02-24 New Safety Warning for Zonisamide/Zonegran Zonisamide FDA
2009-02-19 Updated Safety Information Efalizumab FDA
2009-02-13 Medication Guide Available Mycophenolate Manufacturer
2009-02-05 Recall on Ther-Rx Brand Iron Supplements Chromagen Manufacturer
2009-02-05 Recall on Ther-Rx Brand Iron Supplements Manufacturer
2009-02-05 Recall on Ther-Rx Brand Iron Supplements Manufacturer
2009-02-05 Recall on Ther-Rx Brand Iron Supplements Manufacturer
2009-02-05 Recall on Ther-Rx Brand Iron Supplements Iron Manufacturer
2009-02-05 Recall on ETHEX Brand Iron Supplements Iron Manufacturer
2009-02-05 Recall on Ther-Rx Brand Prenatal Vitamins Prenatal Vitamins Manufacturer
Back to Consumer Med Safety